VRNA - Verona Pharma PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRNA is currently covered by 9 analysts with an average price target of $99.97. This is a potential upside of $13.97 (16.24%) from yesterday's end of day stock price of $86.

Verona Pharma PLC ADR's activity chart (see below) currently has 112 price targets and 96 ratings on display. The stock rating distribution of VRNA is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.62% with an average time for these price targets to be met of 805.67 days.

Highest price target for VRNA is $160, Lowest price target is $107, average price target is $117.6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Jul-2025. First documented stock forecast 22-May-2017.

Currently out of the existing stock ratings of VRNA, 12 are a BUY (66.67%), 6 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-Jul-2025

$107

$21 (24.42%)

$90

8 months 10 days ago
(14-Jul-2025)

25/26 (96.15%)

$2.33 (2.23%)

288

Hold Since 10-Jul-2025

$34

8 months 14 days ago
(10-Jul-2025)

5/5 (100%)

$18.41 (118.09%)

826

Hold Since 10-Jul-2025

$107

$21 (24.42%)

$138

8 months 14 days ago
(10-Jul-2025)

4/7 (57.14%)

$2.15 (2.05%)

113

Hold Since 09-Jul-2025

$107

$21 (24.42%)

$72

8 months 15 days ago
(09-Jul-2025)

13/14 (92.86%)

$2.23 (2.13%)

431

Hold Since 09-Jul-2025

$107

$21 (24.42%)

$110

8 months 15 days ago
(09-Jul-2025)

2/4 (50%)

$2.23 (2.13%)

690

Show more analysts

Please expand the browser size to see the chart

What is VRNA (Verona Pharma PLC ADR) average time for price targets to be met?

On average it took 805.67 days on average for the stock forecasts to be realized with a an average price target met ratio 81.62

Which analyst has the current highest performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?

TIAGO FAUTH

Which analyst has the most public recommendations on VRNA (Verona Pharma PLC ADR)?

Tiago Fauth works at RAYMOND JAMES and has 7 price targets and 4 ratings on VRNA

Which analyst is the currently most bullish on VRNA (Verona Pharma PLC ADR)?

Yasmeen Rahimi with highest potential upside - $74

Which analyst is the currently most reserved on VRNA (Verona Pharma PLC ADR)?

Adam Walsh with lowest potential downside - -$78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?